FrancophonIA/ELRC3.0 huggingface dataset:
English: This is a summary of the European public assessment report (EPAR) for Faslodex.
Maltese: Dan huwa sommarju tar-rapport pubbliku Ewropew ta' valutazzjoni (EPAR) għal Faslodex.
English: The active substance in Faslodex, fulvestrant, is an anti-oestrogen.
Maltese: Is-sustanza attiva f'Faslodex, il-fulvestrant, hija antiestroġenu.
English: Other information about Faslodex
Maltese: Informazzjoni oħra dwar Faslodex
English: Faslodex is available as a solution for injection in prefilled syringes (250 mg).
Maltese: Faslodex jiġi bħala soluzzjoni għall-injezzjoni f'siringi mimlijin għal-lest (250 mg).
English: Finally, a study investigating the use of Faslodex in combination with palbociclib in 521 women with (HR)-positive (HER2)-negative advanced or metastatic breast cancer showed that women treated with Faslodex plus palbociclib lived for an average of 9.2 months without their disease getting worse, compared with 3.8 months for women given Faslodex on its own.
Maltese: Finalment, studju li investiga l-użu ta' Faslodex flimkien ma' palbociclib f'521 mara b'kanċer tas-sider avvanzat jew metastatiku pożittiv (għall-HR) u negattiv (għall-HER2) wera li n-nisa li ġew ikkurati b'Faslodex u palbociclib għexu għal medja ta' 9.2 xhur mingħajr ma l-marda tagħhom marret għallagħar, meta mqabbel ma' 3.8 xhur għal nisa li ngħataw Faslodex waħdu.
English: The fourth study, in 462 women with advanced or metastatic breast cancer who had not been treated with hormonal therapy, showed that women treated with Faslodex (500 mg once a month) lived for an average of 16.6 months without their disease getting worse, compared with 13.8 months for women given anastrozole.
Maltese: Ir-raba' studju, f'462 mara b'kanċer tas-sider avvanzat jew metastatiku li ma ġewx ikkurati b'terapija ormonali, wera li n-nisa li ġew ikkurati b'Faslodex (500 mg darba fix-xahar) għexu għal medja ta' 16.6 xhur mingħajr ma l-marda tagħhom marret għall-agħar, meta mqabbel ma' 13.8 xhur għal nisa li ngħataw anastrozole.
English: • women with a type of breast cancer known as ‘HR-positive, HER-2 negative cancer' who have previously had hormonal treatment.
Maltese: • nisa b'tip ta' kanċer tas-sider magħruf bħala “kanċer pożittiv għall-HR, negattiv għall-HER-2” li ħadu kura ormonali preċedentement.
English: EPAR summary for the public
Maltese: Sommarju tal-EPAR għall-pubbliku fulvestrant
English: When used in combination with palbociclib, the most common side effects with Faslodex (seen in more than 2 patients in 10) are low levels of white and red blood cells, low blood platelet counts, infections, tiredness, nausea, stomatitis (inflammation of the lining of the mouth) and diarrhoea.
Maltese: Meta jintuża flimkien ma' palbociclib, l-effetti sekondarji l-aktar komuni b'Faslodex (li dehru f'aktar minn 2 pazjenti minn kull 10) huma livelli baxxi ta' ċelloli bojod u ħomor tad-demm, għadd tal-pjastrini baxx fid-demm, infezzjonijiet, għeja, nawżja, stomatite (infjammazzjoni tal-kisja tal-ħalq) u dijarea.
English: Why is Faslodex approved?
Maltese: Għaliex ġie approvat Faslodex?
English: A third study in 736 women showed that the higher dose of 500 mg of Faslodex was more effective than 250 mg: women receiving the higher dose lived for an average of 6.5 months without their disease getting worse, compared with 5.5 months in those receiving the lower dose.
Maltese: It-tielet studju f'736 mara wera li d-doża ogħla ta' 500 mg ta' Faslodex kienet aktar effettiva minn 250 mg: nisa li kienu qed jirċievu d-doża ogħla għexu għal medja ta' 6.5 xhur mingħajr ma l-marda tagħhom marret għall-agħar, meta mqabbel ma' 5.5 xhur f'dawk li kienu qed jirċievu d-doża aktar baxxa.
English: How does Faslodex work?
Maltese: Kif jaħdem Faslodex?
English: The recommended dose is 500 mg given once a month, with an additional 500-mg dose two weeks after the first dose.
Maltese: Id-doża rakkomandata hija 500 mg mogħtija darba fix-xahar, b'doża addizzjonali ta' 500 mg ġimagħtejn wara l-ewwel doża.
English: Faslodex is an anti-oestrogen medicine used to treat advanced or metastatic breast cancer (cancer that has spread to other parts of the body) in the following patients:
Maltese: Faslodex huwa mediċina b'antiestroġenu li tintuża biex tikkura kanċer tas-sider avvanzat jew metastatiku (kanċer li jkun infirex għal partijiet oħra tal-ġisem) fil-pazjenti li ġejjin:
English: In women with this type of breast cancer, Faslodex is used in combination with palbociclib (another cancer medicine).
Maltese: F'nisa b'dan it-tip ta' kanċer tas-sider, Faslodex jintuża flimkien ma' palbociclib (mediċina oħra tal-kanċer).
English: What are the risks associated with Faslodex?
Maltese: X'inhuma r-riskji assoċjati ma' Faslodex?
English: Two of these studies in 851 women showed that Faslodex was as effective as another medicine, anastrozole: women receiving Faslodex lived for an average of 5.4 months without their disease getting worse, compared with 4.1 months for those taking anastrozole.
Maltese: Tnejn minn dawn l-istudji fi 851 mara wrew li Faslodex kien effettiv daqs mediċina oħra, anastrozole: nisa li kienu qed jieħdu Faslodex għexu għal medja ta' 5.4 xhur mingħajr ma l-marda tagħhom marret għall-agħar, meta mqabbel ma' 4.1 xhur għal dawk li kienu qed jieħdu anastrozole.
English: In addition, the medicine is effective in combination with palbociclib in patients with HR-positive, HER-2 negative breast cancer.
Maltese: Barra minn hekk, il-mediċina hija effettiva flimkien ma' palbociclib f'pazjenti b'kanċer tas-sider pożittiv għall-HER, negattiv għall-HER-2.
English: When Faslodex is used on its own, the most common side effects (seen in more than 1 patient in 10) are injection-site reactions (such as pain or inflammation), weakness, nausea (feeling sick) and increased liver enzyme levels in the blood (a sign of liver problems).
Maltese: Meta Faslodex jintuża waħdu, l-effetti sekondarji l-aktar komuni (li dehru f'aktar minn pazjent 1 minn kull 10) huma reazzjonijiet fis-sit tal-injezzjoni (bħal uġigħ jew infjammazzjoni), dgħufija, nawżja (tħossok ma tiflaħx) u żieda fil-livelli tal-enzimi tal-fwied fid-demm (sinjal ta' problemi fil-fwied).
English: For the full list of all side effects and restrictions with Faslodex, see the package leaflet.
Maltese: Għal-lista sħiħa tal-effetti sekondarji u r-restrizzjonijiet kollha b'Faslodex, ara l-fuljett ta' tagħrif.
English: The most common serious side effects were low levels of white and red blood cells, low levels of blood platelets, infections, increased liver enzyme levels and tiredness.
Maltese: L-effetti sekondarji serji l-aktar komuni huma livelli baxxi ta' ċelloli bojod u ħomor tad-demm, livelli baxxi talgħadd tal-pjastrini fid-demm, infezzjonijiet, żieda fil-livelli tal-enzimi tal-fwied u għeja.
English: • postmenopausal women with a type of breast cancer known as ‘oestrogen-receptor positive cancer' who have not previously had hormonal treatment, or whose cancer had come back after treatment with another anti-oestrogen;
Maltese: • nisa li jkunu għaddew mill-menopawża b'tip ta' kanċer tas-sider magħruf bħala “kanċer pożittiv għar-riċettur estroġenu” li ma ħadux kura ormonali preċedentement, jew li l-kanċer tagħhom irritorna wara kura b'antiestroġenu ieħor;
English: It blocks the receptors for oestrogen on cells and causes the number of oestrogen receptors to fall.
Maltese: Din timblokka r-riċetturi għal estroġenu fuq iċ-ċelloli u twassal sabiex in-numru ta' riċetturi tal-estroġenu jonqsu.
English: Ref.: EMEA/320256/2009 EMEA/H/C/216
Maltese: EMEA/320256/2009 EMEA/H/C/216
English: It contains the active substance paclitaxel.
Maltese: Fih is-sustanza attiva paclitaxel.
English: Paxene paclitaxel EPAR summary for the public
Maltese: Paxene paclitaxel Sommarju tal-EPAR għall-pubbliku
English: The most common side effects with Paxene (seen in more than 1 patient in 10) are infection, severe neutropenia (very low levels of neutrophils, a type of white blood cell), severe leucopenia (very low white blood cell counts), thrombocytopenia (low blood platelet counts), anaemia (low red blood cell counts), myelosuppression (a condition when the bone marrow cannot make enough blood cells), minor hypersensitivity reactions (allergic reactions), loss of appetite, neuropathy (nerve damage), paraesthesia (unusual sensations like pins and needles), somnolence (sleepiness), hypotension (low blood pressure), nausea (feeling sick), vomiting, diarrhoea, mucosal inflammation (inflammation of the moist body surfaces), constipation, stomatitis (inflammation of the lining of the mouth), abdominal (tummy) pain, alopecia (hair loss), arthralgia (joint pain), myalgia (muscle pain), asthenia (weakness), pain and oedema (swelling).
Maltese: L-effetti sekondarji l-aktar komuni b'Paxene (li dehru f'aktar minn pazjent 1 minn 10) huma infezzjoni, newtropenija gravi (livelli baxxi ħafna ta' newtrofili, tip ta' ċellola bajda tad-demm), lewkopenija gravi (għadd baxx ħafna ta' ċelloli bojod tad-demm), tromboċitopenija (għadd baxx ta' platelets), anemija (għadd baxx ħafna ta' ċelloli ħomor tad-demm), mjelosoppressjoni (kundizzjoni li fiha l-mudullun tal-għadam mhuwiex kapaċi jipproduċi biżżejjed ċelloli tad-demm), reazzjonijiet minuri ta' ipersensittività (reazzjonijiet allerġiċi), telf ta' aptit, newropatija (ħsara fin-nervituri), parestesija (sensazzjonijiet anomali bħat-tnemnim), ħedla tan-ngħas, ipotensjoni (pressjoni tad-demm baxxa), nawżea (dardir), remettar, dijarrea, infjammazzjoni mukożali (infjammazzjoni tal-membrani umdi), stitikezza, stomatite (infjammazzjoni tal-kisi tal-ħalq), uġigħ addominali (ta' żaqq), alopeċja (telf ta' xagħar), artralġija (uġigħ fil-ġogi), mijalġija (uġigħ fil-muskoli), astenija (debbulizza), uġigħ u edema (nefħa).
English: The marketing authorisation was renewed on 19 July 2004 and on 19 July 2009.
Maltese: L-awtorizzazzjoni għat-tqegħid fissuq ġiet mġedda fid-19 ta' Lulju 2004 u fid-19 ta' Lulju 2009.
English: Paxene is an anticancer medicine.
Maltese: Paxene huwa mediċina kontra l-kanċer.
English: What is Paxene?
Maltese: X'inhu Paxene?
English: The European Commission granted a marketing authorisation valid throughout the European Union for Paxene to Norton Healthcare Limited on 19 July 1999.
Maltese: Il-Kummissjoni Ewropea tat awtorizzazzjoni għat-tqegħid fis-suq valida fl-Unjoni Ewropea kollha għal Paxene lil Norton Healthcare Limited fid-19 ta' Lulju 1999.
English: What is the risk associated with Paxene?
Maltese: X'inhuma r-riskji marbuta ma' Paxene?
English: The Committee for Medicinal Products for Human Use (CHMP) decided that Paxene's benefits are greater than its risks for treatment of advanced AIDS-related Kaposi's sarcoma, metastatic breast cancer, advanced cancer of the ovary in combination with cisplatin, metastatic cancer of the ovary where platinum-containing combination therapy has failed, and non-small cell lung cancer.
Maltese: Il-Kumitat għall-Prodotti Mediċinali għall-Użu mill-Bniedem (CHMP) iddeċieda li l-benefiċċji ta' Paxene huma akbar mir-riskji tiegħu fit-trattament tas-sarkoma ta' Kaposi avvanzat relatat mal-AIDS, tal-kanċer tas-sider metastatiku, tal-kanċer tal-ovarji avvanzat f'kombinazzjoni maċ-ċisplatinu, talkanċer tal-ovarji metastatiku wara l-falliment tat-terapija ta' kombinazzjoni li fiha l-platinu u talkanċer tal-pulmun mhux b'ċelloli żgħar.
English: Paxene is a concentrate that is made up into a solution for infusion (drip into a vein).
Maltese: Paxene huwa konċentrat li jitħallat f'soluzzjoni għal infużjoni (dripp ġol-vina).
English: • metastatic cancer of the ovary, when other treatments such as platinum-containing combination therapy have failed;
Maltese: • kanċer tal-ovarji metastatiku, wara l-falliment ta' trattamenti oħra bħat-terapija ta' kombinazzjoni li jkun fiha l-platinu;
English: • advanced AIDS-related Kaposi's sarcoma (a skin cancer often found in AIDS patients), when treatment with anthracyclines (another type of anticancer medicine) has failed;
Maltese: • sarkoma ta' Kaposi avvanzat relatat mal-AIDS (kanċer tal-ġilda li jinsab fil-pazjenti bl-AIDS),
English: In some cases, these were significantly better than with standard anticancer therapy.
Maltese: F'xi wħud mill-każijiet, dawn kienu konsiderevolment aħjar meta mqabbla mat-terapiji tradizzjonali kontra l-kanċer.
English: Paxene has been studied in 107 patients with Kaposi's sarcoma, 312 patients with metastatic breast cancer, 120 patients with metastatic ovarian cancer, over 900 patients with advanced ovarian cancer and over 1,000 patients with lung cancer.
Maltese: Paxene ġie studjat f'107 pazjenti li jbatu mis-sarkoma ta' Kaposi, 312-il pazjent li jbatu mill-kanċer tas-sider metastatiku, 120 pazjent li jbatu mill-kanċer tal-ovarji metastatiku, 'il fuq minn 900 pazjent li jbatu mill-kanċer tal-ovarji avvanzat u 'l fuq minn 1,000 pazjent li jbatu mill-kanċer tal-pulmun.
English: Why has Paxene been approved?
Maltese: Għaliex ġie approvat Paxene?
English: The active substance in Paxene, paclitaxel, belongs to the group of anticancer medicines known as the taxanes.
Maltese: Is-sustanza attiva f'Paxene, paclitaxel, tagħmel parti mill-grupp ta' mediċini kontra l-kanċer magħrufa bħala tassani.
English: • advanced cancer of the ovary (when the cancer has started to spread out of the ovary), in combination with cisplatin (another anticancer medicine);
Maltese: • kanċer tal-ovarji avvanzat (meta l-kanċer beda jinfirex 'il barra mill-ovarji), f'kombinazzjoni maċ ċisplatinu (mediċina oħra kontra l-kanċer);
English: Paxene must not be used in patients with severe liver disease, severe uncontrolled infections or low levels of neutrophils.
Maltese: Paxene ma għandux jintuża f'pazjenti b'mard gravi tal-fwied, b'infezzjonijiet gravi mhux ikkontrollati jew b'livelli baxxi ta' newtrofili.
English: Treatment with Paxene improved the response rates for various types of cancer.
Maltese: Paxene żied ukoll is-sopravivenza ta' xi tipi ta' kanċer.
English: How has Paxene been studied?
Maltese: Kif ġie studjat Paxene?
English: Treatment with Paxene should be given by an oncologist (cancer specialist) in a specialised cancer ward.
Maltese: It-trattament b'Paxene għandu jingħata minn onkologu (speċjalista fil-kura tal-kanċer) f'sala speċjalizzata ta' sptar.
English: As Paxene is very similar to another authorised medicine containing paclitaxel called Taxol, the studies supporting the use of Taxol were used to support the use of Paxene.
Maltese: Paxene huwa simili ħafna għall-mediċina l-oħra awtorizzata li fiha paclitaxel bl-isem ta' Taxol, għaldaqstant l-istudji li jsostnu l-użu ta' Taxol intużaw ukoll biex isostnu l-użu ta' Paxene.
English: In the studies, Paxene was used with other anticancer medicines and compared with other treatments.
Maltese: Flistudji, Paxene intuża flimkien ma' mediċini oħra kontra l-kanċer u tqabbel ma' trattamenti oħra.
English: • non-small cell lung cancer, in combination with cisplatin, when patients cannot have surgery or radiation therapy.
Maltese: • kanċer tal-pulmun mhux b'ċelloli żgħar, f'kombinazzjoni maċ-ċisplatinu, fil-każ ta' pazjenti li ma ġewx sottoposti għal intervent kirurġiku u/jew terapija ta' radjazzjoni.
English: • metastatic breast cancer, when other treatments have failed or cannot be used.
Maltese: • kanċer tal-sider metastatiku, meta trattamenti oħra ma kellhomx suċċess jew ma jistgħux jintużaw.
English: To prevent severe allergic reactions, all patients must first be treated with corticosteroids to reduce inflammation, antihistamines to reduce swelling and itchiness, and H2 antagonists to reduce stomach acid.
Maltese: Biex jiġu evitati reazzjonijiet allerġiċi gravi, il-pazjenti kollha għandhom lewwel ikunu ttrattati bil-kortikosterojdi biex titnaqqas l-infjammazzjoni, bl-antistaminiċi biex jitnaqqsu n-nefħa u l-ħakk u bl-H2 antagonisti biex titnaqqas l-aċidità tal-istonku.
English: For the full list of all side effects reported with Paxene, see the Package Leaflet.
Maltese: Għal-lista sħiħa tal-effetti sekondarji kollha rrapportati ma' Paxene, ara l-Fuljett ta' Tagħrif.
English: Pharmaceuticals Ireland
Maltese: Allergan Pharmaceuticals Ireland
English: Teva Magyarország Zrt
Maltese: Teva Magyarország Zrt Isotretinoin Teva
English: Tretinoina Same Savoma Medicinali
Maltese: Savoma Medicinali Spa Tretinoina Same Savoma Medicinali
English: Arrow Generiques Acnetrait
Maltese: Arrow Generiques
English: Pfdc / Portugal
Maltese: Pfdc / Il-Portugall
English: Genus Pharmaceuticals
Maltese: Acitretin Genus Pharmaceuticals
English: Isotretinoin 500µg G Gel
Maltese: Isotretinoin 500µg G Ġell
English: Ratiopharm Arzneimittel Vertriebs-Gmbh
Maltese: Ratiopharm Arzneimittel VertriebsGmbh
English: Laboratorios Galderma SaSucursal Em Portugal
Maltese: Laboratorios Galderma Sa - Sucursal Em Portugal
English: Pharmaceuticals Limited
Maltese: Genus Pharmaceuticals Limited
English: Topical Application
Maltese: Applikazzjoni Topika
English: Isotretinoin Generics [uk]
Maltese: Generics [uk] Limited Isotretinoin Generics [uk]
English: Galderma (Uk) Limited
Maltese: Galderma (Uk) Limited Differin
English: Tretinoin 15mg/30 G Cream
Maltese: Tretinoin 15mg/30 G Krema
English: Ichthyol-Gesellschaft Cordes, Hermanni & Co. (Gmbh & Co.) Kg
Maltese: Ichthyol-Gesellschaft Cordes, Hermanni & Co.
English: Laboratoires Bailleul Sa
Maltese: Laboratoires Bailleul Sa Erylik
English: Isotretinoin Ranbaxy (Uk)
Maltese: Ranbaxy (Uk) Limited Isotretinoin Ranbaxy (Uk)
English: Tretinoin 0.03g/100 G, Urea 12g/100 G
Maltese: 03g/100 G, Urea 12g/100 G
English: Pharmaceuticals Polska Sp. Z O.O.
Maltese: Teva Pharmaceuticals Polska Sp. Z O.O.
English: Societe D'etudes Et De Recherches Pharmaceutiques (Serp)
Maltese: Societe D'etudes Et De Recherches
English: Adapalene 0.1% Gel
Maltese: Adapalene 0.1%
English: Tretinoin 500µg/Ml, DlAlpha Tocopherol Acetate 100µg/Ml
Maltese: Atrederm 0,05% Tretinoin 500µg/Ml, DlAlpha Tocopherol Acetate 100µg/Ml
English: Isotretinoin 0.05%w/W Gel
Maltese: Isotretinoin 0.05%w/W Ġell
English: Meda Pharma Hungary Kft.
Maltese: Meda Pharma LUngerija Kft.
English: Ehf.
Maltese: A.U.
English: Almirall Hermal Gmbh
Maltese: Almirall Hermal Gmbh Aknenormin
English: Dermapharm Ag Keraderm
Maltese: Dermapharm Ag
English: Acitretin 25mg Tablet
Maltese: Acitretin 25mg Pillola
English: Erythromycin 4g/100 G, Tretinoin 0.025g/100 G Gel
Maltese: Erythromycin 4g/100 G, Tretinoin 0.025g/100 G
English: Glaxosmithkline Gmbh & Co. Kg
Maltese: Glaxosmithkline Gmbh & Co.
English: Pharmaswiss česká Republika S.R.O.
Maltese: Pharmaswiss česká
English: Tretinoin 0.05%w/W Gel
Maltese: Tretinoin 0.05%w/W Ġell
English: Adapalene 0.1%w/W Cream
Maltese: Adapalene 0.1%w/W Krema
English: Mg
Maltese: Kg
English: Galderma Benelux B.V.
Maltese: Galderma Benelux B.V. Differin
English: Galderma International
Maltese: Galderma International Differine
English: Puren Pharma Gmbh & Co. Kg
Maltese: Puren Pharma Gmbh & Co.
English: Roche Latvija Sia Roaccutane
Maltese: Roche Latvija Sia
English: Glaxosmithkline Aebe
Maltese: Glaxosmithkline Aebe Cehado
English: Tretinoin 250µg/Ml, DlAlpha Tocopherol Acetate 50µg/Ml
Maltese: Atrederm 0.025% Tretinoin 250µg/Ml, DlAlpha Tocopherol Acetate 50µg/Ml
English: Adapalene 0.1%w/W Gel
Maltese: Adapalene 0.1%w/W Ġell
English: Meda Pharma
Maltese: Meda Pharma Sas
English: Galderma Laboratorium Gmbh Epiduo
Maltese: Galderma Laboratorium Gmbh
English: Laboratório Medinfar - Produtos Farmacêuticos, S.A.
Maltese: Laboratório MedinfarProdutos Farmacêuticos, S.A.
English: Acitretin 25mg Capsule Capsule
Maltese: Acitretin 25mg Kapsula
English: Adapalene Teva Adapalene 0.1g G
Maltese: Adapalene 0.1g G
English: Ziaja Ltd Zakład Produkcji Leków Sp Z O.O.
Maltese: Produkcji Leków Sp Z O.O.
English: Isotretinoin Ratiopharm Isotretinoin 20mg
Maltese: Ratiopharm Gmbh Isotretinoin Ratiopharm Isotretinoin 20mg
English: Tazarotene 1mg G Gel
Maltese: Tazarotene 1mg G
English: Actavis Group Ptc Acnenor
Maltese: Actavis Group Ptc Ehf. Acnenor
English: Acitren
Maltese: Acitretina
English: Isotretinoin 0.5mg G Cream
Maltese: Isotretinoin 0.5mg G Krema
English: Glaxosmithkline (Cyprus) Limited Isotrexin
Maltese: Glaxosmithkline (Cyprus) Limited
English: Sapiens Pharmaceuticals Ltd Rotren
Maltese: Sapiens Pharmaceuticals Ltd
English: Acitretin 10mg Tablet
Maltese: Acitretin 10mg Pillola
English: Tazarotene 0.5mg G Gel
Maltese: Tazarotene 0.5mg G Ġell
English: Tretinoin 0.05% Cream
Maltese: Tretinoin 0.05%
English: Tazarotene 0.1mg/100 Gel
Maltese: Tazarotene 0.1mg/100 Mg Ġell
English: Glaxosmithkline Slovakia S.R.O.
Maltese: Glaxosmithkline IsSlovakkja S.R.O.
English: Pharmathen Hellas S.A.
Maltese: Pharmathen Hellas S.A. A-Cnotren
English: Meda Pharma S.A.U.
Maltese: Meda Pharma S.P.A.
English: Isotretinoin 0.05g/100 G Gel
Maltese: Isotretinoin 0.05g/100 G Ġell
English: Adapalene 0.1g/100 G Cream
Maltese: Adapalene 0.1g/100 G Krema
English: A-Cnotren
Maltese: L-Iżvezja
English: Acitretin 10mg Capsule Capsule
Maltese: Acitretin 10mg Kapsula
English: Erythromycin 20mgg, Isotretinoin 0.5mgg Gel
Maltese: Erythromycin 20mgg, Isotretinoin 0.5mgg
English: Glaxosmithkline D.O.O.
Maltese: Glaxosmithkline D.O.O. Toctino
English: Tazarotene 0.05g/100 G Gel
Maltese: Tazarotene 0.05g/100 G Ġell
English: Tretinoin 10mg Capsule Capsule, Soft
Maltese: Tretinoin 10mg Kapsula Kapsula, Ratba
English: Tretinoin 0.025g/100 G Cream
Maltese: Tretinoin 0.025g/100 G Krema
English: Isotretinoin Puren
Maltese: Isotretinoina Stiefel
English: Hydrocortisone 10mg G, Tretinoin 1mg G,
Maltese: Hydrocortisone 10mg G, Tretinoin 1mg G, Hydroquinone 50mg G
English: Acitretina Ifc
Maltese: Ifc
English: Tazarotene 0.1g/100 G Gel
Maltese: Tazarotene 0.1g/100 G Ġell
English: Adapalène Zentiva Adapalene 0.1g/100 G Gel
Maltese: Sanofi-Aventis Franza Adapalène Zentiva Adapalene 0.1g/100 G Ġell
English: Glaxosmithkline (Ireland) Limited Isotrexin
Maltese: Glaxosmithkline (Ireland) Limited
English: Meda Pharmaceuticals Ltd Atralin
Maltese: Meda Pharmaceuticals Ltd
English: Isotretinoin Teva
Maltese: Adapalene Teva
English: Isotretinoin Alliance Pharmaceuticals Isotretinoin 5mg Capsule Capsule, Soft
Maltese: Actavis Group Ptc Ehf. Isotretinoin Actavis Isotretinoin 5mg Kapsula Kapsula, Ratba
English: Glaxosmithkline S.R.O.
Maltese: Ir-Repubblika Ċeka Glaxosmithkline S.R.O.
English: Carbamid + Vas Creme
Maltese: Ureotop + Vas
English: Isotretinoin Jenson Isotretinoin 5mg Capsule Capsule, Soft
Maltese: Generics [uk] Limited Isotretinoin Jenson Isotretinoin 5mg Kapsula Kapsula, Ratba
English: Tretinoin 0.05g/100 G Cream
Maltese: Tretinoin 0.05g/100 G Krema
English: Roche Farmacevtska Družba D.O.O.
Maltese: Roche Farmacevtska
English: Erythromycin 20mg G, Isotretinoin 0.05mg G Gel
Maltese: Erythromycin 20mg G, Isotretinoin 0.05mg G
English: Erythromycin 20mg G, Isotretinoin 0.5mg G Gel
Maltese: Erythromycin 20mg G, Isotretinoin 0.5mg G
English: Clindamycin 10mg G, Tretinoin 0.025mg G Gel
Maltese: Clindamycin 10mg G, Tretinoin 0.025mg G
English: Adapalene 0.1g/100g Gel
Maltese: Adapalene 0.1g/100g
English: Aurobindo Pharma B.V.
Maltese: Aurobindo Pharma B.V. Neotigason
English: Dermapharm Ag Isoderm
Maltese: Sp. Z.O.O. Isoderm
English: Tretinoin 0.25mg/Mg Cream
Maltese: Tretinoin 0.25mg/Mg
English: Clindamycin 10mg G, Tretinoin 0.25mg G Gel
Maltese: Clindamycin 10mg G, Tretinoin 0.25mg G
English: Meda Pharma S.P.A. Acnatac
Maltese: Ir-Repubblika Ċeka Meda Pharma S.R.O. Acnatac
English: Tretinoin 0.5mg/Mg Cream
Maltese: Tretinoin 0.5mg/Mg
English: Tretinoin 0.05g/100 Ml
Maltese: Tretinoin 0.05g/100
English: Isosupra Lidose Isotretinoin 8mg Capsule Capsule, Hard
Maltese: Isotretinoína Aurovitas Isotretinoin 10mg Kapsula Kapsula, Ratba
English: Meda Pharma Sia Treclinac
Maltese: Meda Pharma Sia
English: Isotretinoin 0.05mg G Gel
Maltese: Isotretinoin 0.05mg G Ġell
English: Pharmachemie B.V Isotretinoïne Pch
Maltese: Pharmachemie B.V Isotretinoïne Pch Isotretinoin 20mg Kapsula Kapsula
English: Adapalene 0.1g/100 G Gel
Maltese: Adapalene 0.1g/100 G Ġell
English: Laboratoires Smb S.A.
Maltese: Laboratoires Smb S.A. Isosupra Lidose
English: Meda Pharma Gmbh & Co. Kg акнатак 10 Acnatac 10
Maltese: Aurobindo Pharma B.V. Acitretine Aurobindo Acitretin 10mg Biċċa waħda
English: Isotretinoin 5mg Capsule Capsule, Soft
Maltese: Isotretinoin 16mg Kapsula Kapsula, Iebsa
English: Isotretinoin 1mg G Cream
Maltese: Isotretinoin 1mg G
English: Ltd
Maltese: Ml
English: Aebe
Maltese: Zanea
English: Isotretinoin 0.5mg G
Maltese: Isotretinoin 0.5mg G Ġell